Amphastar Pharmaceuticals Community
Create a narrative
WA
Based on Analyst Price Targets
Decisive Acquisitions And Production Innovations Propel Pharma Growth And Market Dominance
US$59.80
FV
19.7% undervalued intrinsic discount11.71%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 3 hours agoauthor updated this narrative